Baseline ctDNA Gene Alterations as a Biomarker of Survival After Panitumumab and Chemotherapy for Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer
Nat. Med. 2024 Feb 12;[EPub Ahead of Print], K Shitara, K Muro, J Watanabe, K Yamazaki, H Ohori, M Shiozawa, A Takashima, M Yokota, A Makiyama, N Akazawa, H Ojima, Y Yuasa, K Miwa, H Yasui, E Oki, T Sato, T Naitoh, Y Komatsu, T Kato, I Mori, K Yamanaka, M Hihara, J Soeda, T Misumi, K Yamamoto, R Yamashita, K Akagi, A Ochiai, H Uetake, K Tsuchihara, T YoshinoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.